Esperion Therapeutics
ESPR
#6434
Rank
S$0.99 B
Marketcap
S$4.17
Share price
-1.20%
Change (1 day)
71.15%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -S$37.01 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are S$0.30 Billion. In 2024 the company made an earning of S$9.48 Million, an increase over its 2023 earnings that were of -S$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$37.01 Million-490.03%
2024 S$9.48 M-104.99%
2023 -S$0.19 Billion-15.03%
2022 -S$0.23 Billion-20.61%
2021 -S$0.29 Billion84.28%
2020 -S$0.16 Billion35.75%
2019 -S$0.12 Billion-55.71%
2018 -S$0.26 Billion19.57%
2017 -S$0.22 Billion125.39%
2016 -S$94.31 Million51.43%
2015 -S$62.28 Million36.45%
2014 -S$45.65 Million43.55%
2013 -S$31.8 Million145.26%
2012 -S$12.97 Million
2002 -S$36.96 Million-7.81%
2001 -S$40.09 Million15.03%
2000 -S$34.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$14.98 B-43,290.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$6.61 B-19,161.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-S$0.66 Billion 1,790.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$86.7 Million 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$6.29 M-118.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.85 B-2,575.39%๐Ÿ‡บ๐Ÿ‡ธ USA